Market Overview

Deutsche Bank Buying Exelon After Pepco Update

Share:

Deutsche Bank continued its Buy rating on Exelon Corporation (NYSE: EXC) after Exelon and merger partner Pepco Holdings, Inc. (NYSE: POM) made a new filing with the Washington DC Public Service Commission (PSC) in what must surely be their final attempt to secure PSC approval for their proposed deal.

The companies also entered an agreement acknowledging that either party may terminate the merger at any time. And Pepco agreed not to declare or pay any further dividends on its common stock unless and until the merger is terminated – or risk losing the pre-paid $180 million break-up fee and $40 million in costs.

Concurrent with the Letter Agreement the companies have filed with the DC PSC requesting "Other Relief" as the PSC indicated they could when rejecting the settlement and proposing alternative terms of its own at the February 26 meeting.

Exelon and Pepco suggest three options for the PSC to move the merger forward, namely 1) approve the original settlement; 2) approve the settlement with the PSC's list of conditions, which EXC and POM both accept; and 3) approve an alternative proposal which the companies suggest may balance the views of the PSC and objections voiced by the other settling parties (e.g. the DC Mayor's office and OPC).

"Options 1 and 2 seem rather unlikely to us given prior positions of the parties, but we imagine the companies are leaving these on the table given the somewhat unusual circumstances where the deal has become caught in a power struggle between some key local interests," analyst Jonathan Arnold said in a client note.

Companies attempt to balance DC parties' competing interests Exelon and Pepco's third option would restore the $25.6 million residential rate credit rather than allowing the PSC to determine allocation. This was a key sticking point for the Mayor and OPC following the PSC's February ruling.

Separately, the companies propose taking $20 million from the MEDSIS (smart meter) program and adding this to the customer benefits bucket to be allocated among classes at the PSC's discretion, with unused balances flowing to MEDSIS. As a result it likely would not trigger most favored nation clause adjustments in other jurisdictions.

"In or view the third option may elegantly balance competing interests of the PSC and other DC parties, although we note these parties are not signatories to the new filing and – at the time of writing – had not commented publicly," Arnold said.

Time-wise the PSC has allowed seven business days for comments (by March 16) with Exelon and Pepco requesting a PSC decision – which would be the third one in this case – by April 7. Per their calendar the PSC are due to meet on March 2, March 16, March 23 and  April 13 although special meetings can be called with 48-hours notice.

Arnold has a $34 price target on Exelon stock, which were trading at $33.85.

Latest Ratings for EXC

DateFirmActionFromTo
Dec 2020Morgan StanleyMaintainsOverweight
Nov 2020MizuhoMaintainsUnderperform
Nov 2020Morgan StanleyMaintainsOverweight

View More Analyst Ratings for EXC
View the Latest Analyst Ratings

 

Related Articles (EXC + POM)

View Comments and Join the Discussion!

Posted-In: Deutsche Bank Jonathan ArnoldAnalyst Color Analyst Ratings

Latest Ratings

StockFirmActionPT
SREMorgan StanleyMaintains143.0
SRMorgan StanleyMaintains68.0
SOMorgan StanleyMaintains56.0
SJIMorgan StanleyMaintains21.0
SHOMorgan StanleyMaintains10.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com